Skip to main content
. 2019 Oct 14;37(34):3291–3299. doi: 10.1200/JCO.19.01389

FIG 1.

FIG 1.

Study flow. (*) KEYNOTE-013. (†) KEYNOTE-170. (‡) Clinical progression refers to patients who, based on clinical signs and symptoms or pathologic findings, had malignant neoplasm progression but did not have progression according to the protocol-specified imaging response criteria (International Working Group 2007) or for whom imaging was not able to be performed for assessment.